Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 536.67 Million CNY | 8.8% |
| 2022 | 493.25 Million CNY | 186.37% |
| 2021 | -571.11 Million CNY | -314.63% |
| 2020 | 266.09 Million CNY | 10.08% |
| 2019 | 241.73 Million CNY | 267.98% |
| 2018 | 65.69 Million CNY | 786.28% |
| 2017 | -9.57 Million CNY | 76.17% |
| 2016 | -40.16 Million CNY | 71.58% |
| 2015 | -141.29 Million CNY | 63.48% |
| 2014 | -386.88 Million CNY | 20.68% |
| 2013 | -487.76 Million CNY | 27.34% |
| 2012 | -671.29 Million CNY | 22.1% |
| 2011 | -861.72 Million CNY | 21.67% |
| 2010 | -1.1 Billion CNY | -1219.52% |
| 2009 | -83.37 Million CNY | 20.45% |
| 2008 | -104.8 Million CNY | -159.11% |
| 2007 | -40.44 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 296.63 Million CNY | -44.73% |
| 2024 Q3 | 889.14 Million CNY | -3.23% |
| 2024 Q2 | 919.52 Million CNY | 209.99% |
| 2023 Q1 | 372.24 Million CNY | -24.53% |
| 2023 FY | 536.67 Million CNY | 8.8% |
| 2023 Q2 | 503.76 Million CNY | 35.33% |
| 2023 Q3 | 296.14 Million CNY | -41.21% |
| 2023 Q4 | 536.67 Million CNY | 81.22% |
| 2022 Q2 | 33.2 Million CNY | 278.63% |
| 2022 Q4 | 493.25 Million CNY | 30.76% |
| 2022 FY | 493.25 Million CNY | 186.37% |
| 2022 Q3 | 377.22 Million CNY | 1035.98% |
| 2022 Q1 | -18.58 Million CNY | 96.75% |
| 2021 Q4 | -571.11 Million CNY | -272.31% |
| 2021 Q1 | 206.97 Million CNY | -22.22% |
| 2021 FY | -571.11 Million CNY | -314.63% |
| 2021 Q2 | 303.92 Million CNY | 46.84% |
| 2021 Q3 | 331.44 Million CNY | 9.05% |
| 2020 Q1 | 489.78 Million CNY | 102.61% |
| 2020 Q2 | 180 Million CNY | -63.25% |
| 2020 FY | 266.09 Million CNY | 10.08% |
| 2020 Q4 | 266.09 Million CNY | 45.45% |
| 2020 Q3 | 182.94 Million CNY | 1.63% |
| 2019 Q2 | 201.96 Million CNY | 12.15% |
| 2019 Q1 | 180.08 Million CNY | 174.14% |
| 2019 FY | 241.73 Million CNY | 267.98% |
| 2019 Q4 | 241.73 Million CNY | 16.33% |
| 2019 Q3 | 207.79 Million CNY | 2.88% |
| 2018 Q1 | 109.29 Million CNY | 1241.84% |
| 2018 Q4 | 65.69 Million CNY | -33.75% |
| 2018 Q3 | 99.16 Million CNY | 405.29% |
| 2018 FY | 65.69 Million CNY | 786.28% |
| 2018 Q2 | -32.48 Million CNY | -129.72% |
| 2017 Q3 | 61 Million CNY | -34.92% |
| 2017 Q2 | 93.74 Million CNY | 167.34% |
| 2017 Q1 | -139.2 Million CNY | -246.63% |
| 2017 FY | -9.57 Million CNY | 76.17% |
| 2017 Q4 | -9.57 Million CNY | -115.69% |
| 2016 Q1 | -76.63 Million CNY | 45.76% |
| 2016 Q2 | -19.36 Million CNY | 74.73% |
| 2016 Q3 | -68.15 Million CNY | -251.95% |
| 2016 Q4 | -40.16 Million CNY | 41.08% |
| 2016 FY | -40.16 Million CNY | 71.58% |
| 2015 Q4 | -141.29 Million CNY | -431.64% |
| 2015 Q2 | -140.2 Million CNY | 40.04% |
| 2015 Q1 | -233.83 Million CNY | 39.56% |
| 2015 FY | -141.29 Million CNY | 63.48% |
| 2015 Q3 | -26.57 Million CNY | 81.04% |
| 2014 Q1 | -466.59 Million CNY | 4.34% |
| 2014 FY | -386.88 Million CNY | 20.68% |
| 2014 Q2 | -404.07 Million CNY | 13.4% |
| 2014 Q4 | -386.88 Million CNY | -0.72% |
| 2014 Q3 | -384.12 Million CNY | 4.94% |
| 2013 Q2 | -510.49 Million CNY | 15.49% |
| 2013 Q3 | -470.9 Million CNY | 7.76% |
| 2013 Q1 | -604.04 Million CNY | 10.02% |
| 2013 Q4 | -487.76 Million CNY | -3.58% |
| 2013 FY | -487.76 Million CNY | 27.34% |
| 2012 Q1 | -820.05 Million CNY | 4.84% |
| 2012 Q2 | -759.91 Million CNY | 7.33% |
| 2012 Q3 | -630.86 Million CNY | 16.98% |
| 2012 FY | -671.29 Million CNY | 22.1% |
| 2012 Q4 | -671.29 Million CNY | -6.41% |
| 2011 Q3 | -895.46 Million CNY | 5.44% |
| 2011 Q1 | -1.02 Billion CNY | 6.62% |
| 2011 Q2 | -947 Million CNY | 7.82% |
| 2011 Q4 | -861.72 Million CNY | 3.77% |
| 2011 FY | -861.72 Million CNY | 21.67% |
| 2010 Q2 | -40.75 Million CNY | 0.0% |
| 2010 FY | -1.1 Billion CNY | -1219.52% |
| 2010 Q4 | -1.1 Billion CNY | -1.87% |
| 2010 Q3 | -1.07 Billion CNY | -2549.71% |
| 2009 FY | -83.37 Million CNY | 20.45% |
| 2009 Q4 | -83.37 Million CNY | 0.0% |
| 2008 FY | -104.8 Million CNY | -159.11% |
| 2007 FY | -40.44 Million CNY | 0.0% |